ADDERALL Safety Questions, ADDERALL Answers


More Here>>Side Effects - FDA Reports 2006-2008

Medications A-Z:   A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Welcome! Patientsville.com provides unique information about ADDERALL. Our extensive database of ADDERALL adverse events and ADDERALL warnings is updated regularly. If you have questions, you can post them to one of our health experts or ask others in our broad patient community.

>> Announcements
Check out our Hospital and Home Care Quality Reports.

Ask Our Health Experts about ADDERALL

Do You Have a Question about Your Health?

Our Doctors and Nurses will Help You Understand Your Symptoms and Feel Better!
Private, Confidential and Discreet



ADDERALL Safety Reports

Total ADDERALL reports: 153.
ADDERALL FDA safety alerts: 2005 .
Reported deaths: 19    Reported hospitalizations: 50.
Take ADDERALL Side Effects Survey or Share Your ADDERALL Story. ADDERALL Usage.

Showing 1-75 of 153 Next >

Health Professional from UNITED STATES reported ADDERALL problem on May 18, 2007. Male patient, weighting 170.0 lb, was diagnosed with attention deficit/hyperactivity disorder and was treated with ADDERALL. After drug was administered, patient experienced the following problems/side effects: aggression. ADDERALL dosage: 30 MG QD PO. Patient was hospitalized. Patient recovered.

ADDERALL problem was reported by a Consumer or non-health professional from UNITED STATES on May 09, 2007. Female patient, 47 years of age, weighting 119.0 lb, was diagnosed with attention deficit/hyperactivity disorder and was treated with ADDERALL. After drug was administered, patient experienced the following problems/side effects: bone neoplasm, decreased appetite, dry mouth, dysphonia, headache, hepatic neoplasm, renal neoplasm, tumour invasion, weight decreased. ADDERALL dosage: unknown. During the same period patient was treated with STRATTERA, SARAFEM. Patient recovered.

Consumer or non-health professional from UNITED STATES reported ADDERALL problem on May 07, 2007. Male patient, 31 years of age, was diagnosed with attention deficit/hyperactivity disorder and was treated with ADDERALL. After drug was administered, patient experienced the following problems/side effects: blood uric acid increased, gout, hepatic steatosis, hepatomegaly, liver disorder, pain in extremity. ADDERALL dosage: unknown. Patient recovered.

ADDERALL problem was reported by a Consumer or non-health professional from UNITED STATES on May 09, 2007. Male patient, 16 years of age, weighting 224.9 lb, was diagnosed with attention deficit/hyperactivity disorder and was treated with ADDERALL. After drug was administered, patient experienced the following problems/side effects: aggression, apathy, depression, disturbance in attention, educational problem, hyperhidrosis, suicidal ideation, treatment noncompliance. ADDERALL dosage: unknown. Patient recovered.

Consumer or non-health professional from UNITED STATES reported ADDERALL problem on May 29, 2007. Female patient was diagnosed with attention deficit/hyperactivity disorder and was treated with ADDERALL. After drug was administered, patient experienced the following problems/side effects: congestive cardiomyopathy. ADDERALL dosage: unknown. Patient was hospitalized. Patient recovered.

ADDERALL problem was reported by a Consumer or non-health professional from UNITED STATES on May 29, 2007. Female patient, 31 years of age, weighting 118.0 lb, was diagnosed with attention deficit/hyperactivity disorder and was treated with ADDERALL. After drug was administered, patient experienced the following problems/side effects: alopecia. ADDERALL dosage: 20MG DAILY PO. Patient recovered.

Pharmacist from UNITED STATES reported ADDERALL problem on May 31, 2007. Male patient, 15 years of age, weighting 137.3 lb, was diagnosed with attention deficit/hyperactivity disorder and was treated with ADDERALL. After drug was administered, patient experienced the following problems/side effects: abdominal pain, flank pain, rhabdomyolysis. ADDERALL dosage: 20MG DAILY ORAL. Patient was hospitalized. Patient recovered.

ADDERALL problem was reported by a Pharmacist from UNITED STATES on May 31, 2007. Male patient, weighting 137.0 lb, was diagnosed with attention deficit/hyperactivity disorder and was treated with ADDERALL. After drug was administered, patient experienced the following problems/side effects: back pain, haematuria, kidney infection, leukocytosis, liver function test abnormal, rhabdomyolysis, urine colour abnormal. ADDERALL dosage: 20 MG DAILY PO. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported ADDERALL problem on May 29, 2007. Male patient, 14 years of age, weighting 112.0 lb, was diagnosed with attention deficit/hyperactivity disorder and was treated with ADDERALL. After drug was administered, patient experienced the following problems/side effects: abnormal behaviour, aggression, hostility, legal problem, suicidal ideation, verbally abused. ADDERALL dosage: unknown. Patient recovered.

ADDERALL problem was reported by a Physician from CANADA on May 29, 2007. Male patient, 15 years of age, was treated with ADDERALL. After drug was administered, patient experienced the following problems/side effects: loss of consciousness. ADDERALL dosage: 25 MG. Patient recovered.

Health Professional from UNITED STATES reported ADDERALL problem on May 25, 2007. Male patient, weighting 160.1 lb, was diagnosed with attention deficit/hyperactivity disorder and was treated with ADDERALL. After drug was administered, patient experienced the following problems/side effects: abdominal pain, splenomegaly. ADDERALL dosage: unknown. During the same period patient was treated with WELLBUTRIN. Patient was hospitalized. Patient recovered.

ADDERALL problem was reported by a Consumer or non-health professional from UNITED STATES on May 23, 2007. Male patient was diagnosed with muscle twitching and was treated with ADDERALL. ADDERALL dosage: unknown. Patient died.

Consumer or non-health professional from UNITED STATES reported ADDERALL problem on June 15, 2007. Male patient, child 8 years of age, weighting 60.00 lb, was diagnosed with attention deficit/hyperactivity disorder and was treated with ADDERALL. After drug was administered, patient experienced the following problems/side effects: abnormal behaviour, family stress, incorrect dose administered. ADDERALL dosage: ONE 25MG CAPSULE 1 / DAY PO. Patient recovered.

ADDERALL problem was reported by a Physician from UNITED STATES on June 25, 2007. Female patient was diagnosed with attention deficit/hyperactivity disorder and was treated with ADDERALL. After drug was administered, patient experienced the following problems/side effects: decreased appetite, weight decreased. ADDERALL dosage: 5MG PO. Patient recovered.

Consumer or non-health professional from UNITED STATES reported ADDERALL problem on June 12, 2007. Male patient, child 9 years of age, weighting 50.04 lb, was treated with ADDERALL. After drug was administered, patient experienced the following problems/side effects: cardiac arrest. ADDERALL dosage: unknown. Patient was hospitalized. Patient recovered.

ADDERALL problem was reported by a Consumer or non-health professional from UNITED STATES on July 03, 2006. Female patient, 50 years of age, weighting 152.0 lb, was diagnosed with attention deficit/hyperactivity disorder and was treated with ADDERALL. After drug was administered, patient experienced the following problems/side effects: anxiety, asthenia, somnolence. ADDERALL dosage: 20MG 2 PO. Patient recovered.

Pharmacist from UNITED STATES reported ADDERALL problem on July 03, 2006. Male patient, child 11 years of age, weighting 61.29 lb, was treated with ADDERALL. After drug was administered, patient experienced the following problems/side effects: chest pain, decreased appetite, fatigue, tachycardia. ADDERALL dosage: unknown. Patient recovered.

ADDERALL problem was reported by a Consumer or non-health professional from UNITED STATES on June 20, 2006. Female patient, child 6 years of age, weighting 39.90 lb, was diagnosed with disturbance in attention and was treated with ADDERALL. After drug was administered, patient experienced the following problems/side effects: abnormal behaviour, glaucoma. ADDERALL dosage: unknown. Patient recovered.

Physician from UNITED STATES reported ADDERALL problem on June 27, 2006. Male patient, child 9 years of age, weighting 65.92 lb, was diagnosed with attention deficit/hyperactivity disorder and was treated with ADDERALL. After drug was administered, patient experienced the following problems/side effects: abnormal behaviour, blood potassium decreased, brain stem syndrome, cerebral ischaemia, chest pain, confusional state, convulsion, diabetes insipidus. ADDERALL dosage: unknown. During the same period patient was treated with SEROQUEL, GUANFACINE HYDROCHLORIDE. Patient died on 04/11/2006.

ADDERALL problem was reported by a Consumer or non-health professional from UNITED STATES on June 21, 2006. Male patient, 13 years of age, was diagnosed with attention deficit/hyperactivity disorder, insomnia, depression and was treated with ADDERALL. After drug was administered, patient experienced the following problems/side effects: malaise, myocarditis bacterial, pharyngitis streptococcal, prescribed overdose. ADDERALL dosage: 20 MG; BID; ORAL. During the same period patient was treated with CLONIDINE, PROZAC, AMOXICILLIN. Patient died on 03/26/2006.

Consumer or non-health professional from UNITED STATES reported ADDERALL problem on July 01, 2006. Male patient, 31 years of age, was diagnosed with attention deficit/hyperactivity disorder and was treated with ADDERALL. After drug was administered, patient experienced the following problems/side effects: feeling abnormal, prescribed overdose, rectal haemorrhage. ADDERALL dosage: 30 MG DAILY. Patient recovered.

ADDERALL problem was reported by a Physician from UNITED STATES on June 29, 2006. Female patient, 16 years of age, weighting 115.1 lb, was treated with ADDERALL. After drug was administered, patient experienced the following problems/side effects: agitation, dyskinesia, feeling abnormal, hallucination, visual, hypertension, loss of consciousness, paranoia, refusal of treatment by relative. ADDERALL dosage: 15 MG, ONCE DOSE, ORAL. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported ADDERALL problem on July 21, 2006. Male patient, weighting 165.0 lb, was treated with ADDERALL. After drug was administered, patient experienced the following problems/side effects: disturbance in attention, fatigue, impaired work ability. ADDERALL dosage: unknown. Patient recovered.

ADDERALL problem was reported by a Health Professional from UNITED STATES on July 18, 2006. Female patient, 31 years of age, was treated with ADDERALL. After drug was administered, patient experienced the following problems/side effects: acute myocardial infarction, coronary artery aneurysm, coronary artery perforation. ADDERALL dosage: unknown. Patient recovered.

Consumer or non-health professional from UNITED STATES reported ADDERALL problem on July 28, 2006. Male patient, 14 years of age, weighting 150.0 lb, was treated with ADDERALL. After drug was administered, patient experienced the following problems/side effects: arrhythmogenic right ventricular dysplasia, fall. ADDERALL dosage: unknown. Patient died on 10/21/2004.

ADDERALL problem was reported by a Health Professional from UNITED STATES on July 20, 2006. Female patient, 31 years of age, was treated with ADDERALL. After drug was administered, patient experienced the following problems/side effects: acute myocardial infarction, coronary artery aneurysm, coronary artery occlusion, coronary artery perforation, coronary artery thrombosis, extravasation, ventricular hypokinesia. ADDERALL dosage: unknown. During the same period patient was treated with ORAL CONTRACEPTIVE NOS, LEVOTHYROXINE. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported ADDERALL problem on Aug 08, 2006. Female patient, child 11 years of age, weighting 57.98 lb, was diagnosed with attention deficit/hyperactivity disorder and was treated with ADDERALL. After drug was administered, patient experienced the following problems/side effects: alopecia areata, crystal urine present, eosinophil count increased. ADDERALL dosage: 10 MG, 1X/DAY:QD. Patient recovered.

ADDERALL problem was reported by a Physician from UNITED STATES on Aug 02, 2006. Male patient, 32 years of age, weighting 255.5 lb, was diagnosed with attention deficit/hyperactivity disorder and was treated with ADDERALL. After drug was administered, patient experienced the following problems/side effects: depression, incorrect dose administered, nephritis interstitial, overdose, prescribed overdose, renal failure acute, renal tubular necrosis, rhabdomyolysis. ADDERALL dosage: 25 MG 4 TO 5 CUP DAILY. During the same period patient was treated with TYLENOL. Patient recovered.

Consumer or non-health professional from UNITED STATES reported ADDERALL problem on Aug 03, 2006. Male patient, child 5 years of age, was diagnosed with attention deficit/hyperactivity disorder and was treated with ADDERALL. After drug was administered, patient experienced the following problems/side effects: abnormal behaviour, aggression, agitation, crying, rebound effect, weight decreased. ADDERALL dosage: unknown. Patient recovered.

ADDERALL problem was reported by a Health Professional from UNITED STATES on Aug 04, 2006. Male patient, 13 years of age, was diagnosed with attention deficit/hyperactivity disorder, insomnia, depression and was treated with ADDERALL. After drug was administered, patient experienced the following problems/side effects: malaise, myocarditis bacterial, pharyngitis streptococcal, streptococcal infection. ADDERALL dosage: 20 MG BID ORAL. During the same period patient was treated with CLONIDINE, PROZAC, AMOXICILLIN. Patient died on 03/26/2006.

Physician from UNITED STATES reported ADDERALL problem on Aug 30, 2006. Male patient, 50 years of age, weighting 194.0 lb, was diagnosed with attention deficit/hyperactivity disorder and was treated with ADDERALL. After drug was administered, patient experienced the following problems/side effects: cardiac failure congestive, congestive cardiomyopathy, ejection fraction decreased. ADDERALL dosage: 30 MG TID PO. Patient was hospitalized. Patient recovered.

ADDERALL problem was reported by a Consumer or non-health professional from UNITED STATES on Aug 31, 2006. Male patient, 30 years of age, weighting 200.0 lb, was diagnosed with attention deficit/hyperactivity disorder and was treated with ADDERALL. After drug was administered, patient experienced the following problems/side effects: amnesia, cardiomyopathy, fall, heat stroke, hot flush, hypertension, loss of consciousness, memory impairment, paraesthesia. ADDERALL dosage: 20 MG, 2X/DAY: BID,. During the same period patient was treated with LEXAPRO, VITAMINS. Patient recovered.

Physician from UNITED STATES reported ADDERALL problem on Sept 15, 2006. Male patient, 17 years of age, weighting 179.9 lb, was diagnosed with attention deficit/hyperactivity disorder and was treated with ADDERALL. After drug was administered, patient experienced the following problems/side effects: arrhythmia, fall, ill-defined disorder, myocardial fibrosis. ADDERALL dosage: unknown. During the same period patient was treated with LAMICTAL, SYNTHROID. Patient died on 04/23/2006.

ADDERALL problem was reported by a Physician from UNITED STATES on Sept 19, 2006. Male patient, 18 years of age, weighting 177.0 lb, was diagnosed with attention deficit/hyperactivity disorder and was treated with ADDERALL. After drug was administered, patient experienced the following problems/side effects: abnormal behaviour, affect lability, aggression, blood bilirubin increased, blood pressure decreased, concussion, condition aggravated, fall. ADDERALL dosage: unknown. During the same period patient was treated with SEROQUEL. Patient was hospitalized. Patient recovered.

Health Professional from AUSTRALIA reported ADDERALL problem on Sept 20, 2006. Male patient, 39 years of age, was treated with ADDERALL. After drug was administered, patient experienced the following problems/side effects: finger amputation, gangrene. ADDERALL dosage: unknown. Patient was hospitalized. Patient recovered.

ADDERALL problem was reported by a Consumer or non-health professional from UNITED STATES on Sept 20, 2006. Male patient was treated with ADDERALL. After drug was administered, patient experienced the following problems/side effects: chest pain, disturbance in attention, hypoaesthesia, paralysis, prescribed overdose, sluggishness. ADDERALL dosage: 40 MG DAILY; SEE IMAGE. Patient recovered.

Consumer or non-health professional from UNITED STATES reported ADDERALL problem on Sept 20, 2006. Male patient, 39 years of age, weighting 200.0 lb, was diagnosed with attention deficit/hyperactivity disorder and was treated with ADDERALL. After drug was administered, patient experienced the following problems/side effects: anorexia, anxiety, chest pain, disturbance in attention, dizziness, dyspnoea, fear, hypoaesthesia. ADDERALL dosage: 40 MG DAILY; 10 MG DAILY; 20 MG DAILY; 15 MG DAILY. During the same period patient was treated with ADDERALL XR, WELLBUTRIN. Patient recovered.

ADDERALL problem was reported by a Consumer or non-health professional from UNITED STATES on Sept 29, 2006. Male patient, child 8 years of age, was diagnosed with attention deficit/hyperactivity disorder and was treated with ADDERALL. After drug was administered, patient experienced the following problems/side effects: borderline glaucoma, migraine. ADDERALL dosage: 10 MG, 1X/DAY; QD. Patient recovered.

Physician from UNITED STATES reported ADDERALL problem on Oct 12, 2006. Female patient, 20 years of age, weighting 115.1 lb, was diagnosed with attention deficit/hyperactivity disorder and was treated with ADDERALL. After drug was administered, patient experienced the following problems/side effects: pneumothorax. ADDERALL dosage: unknown. Patient was hospitalized. Patient recovered.

ADDERALL problem was reported by a Consumer or non-health professional from UNITED STATES on Oct 18, 2006. Male patient, 13 years of age, weighting 110.0 lb, was treated with ADDERALL. After drug was administered, patient experienced the following problems/side effects: escherichia infection, kidney infection. ADDERALL dosage: 25 MG, ORAL. During the same period patient was treated with BENADRYL, MELATONIN. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported ADDERALL problem on Oct 30, 2006. Male patient, child 4 years of age, was diagnosed with attention deficit/hyperactivity disorder and was treated with ADDERALL. After drug was administered, patient experienced the following problems/side effects: colitis, headache, mydriasis, prescribed overdose, toxic shock syndrome. ADDERALL dosage: 30 MG, 1X/DAY, QD, ORAL. Patient was hospitalized. Patient recovered.

ADDERALL problem was reported by a Health Professional from UNITED STATES on Nov 13, 2006. Female patient, weighting 114.0 lb, was treated with ADDERALL. After drug was administered, patient experienced the following problems/side effects: bruxism. ADDERALL dosage: unknown. Patient recovered.

Health Professional from UNITED STATES reported ADDERALL problem on Nov 10, 2006. Male patient, 14 years of age, weighting 198.0 lb, was diagnosed with attention deficit/hyperactivity disorder and was treated with ADDERALL. After drug was administered, patient experienced the following problems/side effects: chest pain, palpitations, tremor. ADDERALL dosage: 5MG TWICE DAILY P.O.. Patient recovered.

ADDERALL problem was reported by a Consumer or non-health professional from UNITED STATES on Nov 20, 2006. Male patient, child 7 years of age, weighting 77.00 lb, was diagnosed with attention deficit/hyperactivity disorder and was treated with ADDERALL. After drug was administered, patient experienced the following problems/side effects: hallucinations, mixed, suicidal ideation. ADDERALL dosage: unknown. Patient recovered.

Physician from UNITED STATES reported ADDERALL problem on Nov 10, 2006. Female patient, 42 years of age, was treated with ADDERALL. After drug was administered, patient experienced the following problems/side effects: completed suicide. ADDERALL dosage: unknown. During the same period patient was treated with BUPROPION, METHAMPHETAMINE. Patient died.

ADDERALL problem was reported by a Physician from UNITED STATES on Nov 10, 2006. Female patient, 48 years of age, was treated with ADDERALL. After drug was administered, patient experienced the following problems/side effects: completed suicide. ADDERALL dosage: unknown. During the same period patient was treated with SERTRALINE. Patient died.

Physician from UNITED STATES reported ADDERALL problem on Nov 10, 2006. Female patient, 32 years of age, was treated with ADDERALL. After drug was administered, patient experienced the following problems/side effects: completed suicide. ADDERALL dosage: unknown. During the same period patient was treated with VALPROIC ACID, INSULIN. Patient died.

ADDERALL problem was reported by a Physician from UNITED STATES on Nov 10, 2006. Female patient, 40 years of age, was treated with ADDERALL. ADDERALL dosage: unknown. During the same period patient was treated with ETHANOL. Patient died.

Physician from UNITED STATES reported ADDERALL problem on Nov 28, 2006. Female patient was treated with ADDERALL. After drug was administered, patient experienced the following problems/side effects: abdominal pain upper. ADDERALL dosage: 20MG TID. Patient recovered.

ADDERALL problem was reported by a Physician from UNITED STATES on Nov 21, 2006. Male patient, 14 years of age, weighting 121.0 lb, was diagnosed with attention deficit/hyperactivity disorder and was treated with ADDERALL. After drug was administered, patient experienced the following problems/side effects: hypoglycaemic coma. ADDERALL dosage: 30 MG, 1X/DAY; QD, ORAL. During the same period patient was treated with LAMICTAL. Patient recovered.

Consumer or non-health professional from UNITED STATES reported ADDERALL problem on Nov 16, 2006. Female patient, 30 years of age, weighting 119.9 lb, was diagnosed with attention deficit/hyperactivity disorder and was treated with ADDERALL. After drug was administered, patient experienced the following problems/side effects: anxiety, headache, loss of consciousness, mood altered, palpitations. ADDERALL dosage: unknown. During the same period patient was treated with CALCI. Patient recovered.

ADDERALL problem was reported by a Physician from UNITED STATES on Nov 27, 2006. Female patient, 31 years of age, weighting 115.1 lb, was diagnosed with temporal lobe epilepsy and was treated with ADDERALL. After drug was administered, patient experienced the following problems/side effects: aggression, agitation, anterograde amnesia, cognitive disorder, compulsions, confusional state, delirium, depression suicidal. ADDERALL dosage: 30 MG, 2X/DAY: BID, ORAL. During the same period patient was treated with GABITRIL, XANAX, NEURONTIN, LEXAPRO, SYNTHROID, KEPPRA, REMERON. Patient was hospitalized. Patient recovered.

Physician from CANADA reported ADDERALL problem on Dec 04, 2006. Male patient, 24 years of age, was diagnosed with attention deficit/hyperactivity disorder and was treated with ADDERALL. After drug was administered, patient experienced the following problems/side effects: arrhythmia. ADDERALL dosage: 15 MG 1X/DAY, QD; ORAL. During the same period patient was treated with VENTOLIN, CORTICOSTEROIDS INHALER. Patient recovered.

ADDERALL problem was reported by a Physician from UNITED STATES on Dec 15, 2006. Male patient, 16 years of age, was diagnosed with attention deficit/hyperactivity disorder and was treated with ADDERALL. After drug was administered, patient experienced the following problems/side effects: dizziness, facial palsy, fatigue, hypoaesthesia oral, joint stiffness, muscle tightness, pharyngeal hypoaesthesia. ADDERALL dosage: 20 MG, 1X/DAY: QD, ORAL. During the same period patient was treated with PROZAC. Patient was hospitalized. Patient recovered.

Physician from UNITED STATES reported ADDERALL problem on Dec 28, 2006. Female patient, weighting 140.0 lb, was diagnosed with attention deficit/hyperactivity disorder and was treated with ADDERALL. After drug was administered, patient experienced the following problems/side effects: cold sweat, dyspnoea, fall, feeling cold, headache, hyperhidrosis, neck injury, swollen tongue. ADDERALL dosage: unknown. During the same period patient was treated with EPINEPHRINE. Patient recovered.

ADDERALL problem was reported by a Health Professional from UNITED STATES on June 27, 2007. Male patient, 22 years of age, was treated with ADDERALL. After drug was administered, patient experienced the following problems/side effects: acute respiratory distress syndrome, aspiration, bacterial infection, blood pressure decreased, bronchopleural fistula, cardiovascular disorder, hepatic failure, hypovolaemia. ADDERALL dosage: 50 MG, ONCE, ORAL. During the same period patient was treated with MODAFINIL, ZONISAMIDE. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported ADDERALL problem on July 03, 2007. Female patient, child 8 years of age, was diagnosed with attention deficit/hyperactivity disorder and was treated with ADDERALL. After drug was administered, patient experienced the following problems/side effects: fall, overdose, upper limb fracture. ADDERALL dosage: 20 MG, 2X/DAY/BID. During the same period patient was treated with STRATTERA, CLONIDINE. Patient was hospitalized. Patient recovered.

ADDERALL problem was reported by a Consumer or non-health professional from UNITED STATES on July 27, 2007. Male patient, weighting 93.26 lb, was diagnosed with attention deficit/hyperactivity disorder and was treated with ADDERALL. After drug was administered, patient experienced the following problems/side effects: epistaxis, headache, hypertension. ADDERALL dosage: unknown. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported ADDERALL problem on July 27, 2007. Male patient, weighting 93.26 lb, was diagnosed with attention deficit/hyperactivity disorder and was treated with ADDERALL. After drug was administered, patient experienced the following problems/side effects: hypertension. ADDERALL dosage: unknown. Patient was hospitalized. Patient recovered.

ADDERALL problem was reported by a Consumer or non-health professional from UNITED STATES on July 10, 2007. Male patient, 14 years of age, weighting 106.0 lb, was diagnosed with attention deficit/hyperactivity disorder and was treated with ADDERALL. After drug was administered, patient experienced the following problems/side effects: collapse of lung, intestinal obstruction, respiratory tract infection. ADDERALL dosage: 10 MG, 1X/DAY:QD, ORAL; 15 MG, 1X/DAY:QD, ORAL; 20 MG;1X/DAY:QD, ORAL. During the same period patient was treated with MACRODANTIN, DITROPAN. Patient was hospitalized. Patient recovered.

Health Professional from UNITED STATES reported ADDERALL problem on July 16, 2007. Female patient, 15 years of age, weighting 155.0 lb, was diagnosed with attention deficit/hyperactivity disorder and was treated with ADDERALL. After drug was administered, patient experienced the following problems/side effects: paresis cranial nerve. ADDERALL dosage: 20 MG, 1X/DAY;QD. During the same period patient was treated with ADDERALL XR, MOTRIN. Patient recovered.

ADDERALL problem was reported by a Consumer or non-health professional from UNITED STATES on July 16, 2007. Male patient, child 10 years of age, weighting 65.04 lb, was diagnosed with attention deficit/hyperactivity disorder and was treated with ADDERALL. After drug was administered, patient experienced the following problems/side effects: anger, depression, emotional disorder, mental disorder, psychomotor hyperactivity, suicidal ideation, treatment noncompliance. ADDERALL dosage: unknown. During the same period patient was treated with DAYTRANA. Patient recovered.

Physician from UNITED STATES reported ADDERALL problem on July 16, 2007. Male patient, 26 years of age, weighting 160.1 lb, was diagnosed with attention deficit/hyperactivity disorder and was treated with ADDERALL. After drug was administered, patient experienced the following problems/side effects: insomnia, somnolence. ADDERALL dosage: 25 MG, 1X/DAY:QD,. Patient was hospitalized. Patient recovered.

ADDERALL problem was reported by a Physician from UNITED STATES on July 25, 2007. Female patient, 39 years of age, was diagnosed with attention deficit/hyperactivity disorder and was treated with ADDERALL. After drug was administered, patient experienced the following problems/side effects: benign intracranial hypertension, visual disturbance. ADDERALL dosage: 30 MG, 1X/DAY;QD AM, ORAL. During the same period patient was treated with ZOLOFT. Patient recovered.

Consumer or non-health professional from UNITED STATES reported ADDERALL problem on July 23, 2007. Male patient, child 11 years of age, was diagnosed with attention deficit/hyperactivity disorder and was treated with ADDERALL. After drug was administered, patient experienced the following problems/side effects: aggression, condition aggravated, physical assault, violence-related symptom. ADDERALL dosage: 30 MG, 1X/DAY; QD, ORAL. During the same period patient was treated with DEPAKOTE, CLONIDINE, ABILIFY. Patient recovered.

ADDERALL problem was reported by a Health Professional from UNITED STATES on July 25, 2007. Male patient, 22 years of age, was treated with ADDERALL. After drug was administered, patient experienced the following problems/side effects: acute respiratory distress syndrome, aspiration, blood pressure decreased, bronchopleural fistula, cardiac disorder, condition aggravated, convulsive threshold lowered, encephalopathy. ADDERALL dosage: 50 MG, ONCE, ORAL. During the same period patient was treated with MODAFINIL, ZONISAMIDE. Patient was hospitalized. Patient died on 07/10/2007.

Consumer or non-health professional from UNITED STATES reported ADDERALL problem on Aug 06, 2007. Male patient, child 11 years of age, was diagnosed with attention deficit/hyperactivity disorder and was treated with ADDERALL. After drug was administered, patient experienced the following problems/side effects: aggression, condition aggravated, physical assault, psychiatric symptom. ADDERALL dosage: unknown. During the same period patient was treated with DEPAKOTE, CLONIDINE, ABILIFY. Patient recovered.

ADDERALL problem was reported by a Consumer or non-health professional from UNITED STATES on Aug 17, 2007. Male patient, weighting 209.9 lb, was diagnosed with attention deficit/hyperactivity disorder and was treated with ADDERALL. After drug was administered, patient experienced the following problems/side effects: contusion, hepatic haemorrhage, hepatitis c, homicidal ideation, psychotic disorder, self-injurious ideation. ADDERALL dosage: 20 MG, QID, ORAL, 20 MG, TID, ORAL. During the same period patient was treated with INSULIN, METFORMIN, GLIPIZIDE, LITHIUM CARBONATE. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported ADDERALL problem on Aug 20, 2007. Female patient, 54 years of age, was diagnosed with attention deficit/hyperactivity disorder, hepatitis c virus, hepatitis viral and was treated with ADDERALL. After drug was administered, patient experienced the following problems/side effects: abdominal pain, affect lability, alopecia, anger, anxiety, arthropod bite, dehydration, depression, diarrhoea. ADDERALL dosage: 10 MG, ORAL. During the same period patient was treated with PEGASYS, RIBAVIRIN, TOPROL, HYDROCHLORZIDE, TRILEPTAL. Patient recovered.

ADDERALL problem was reported by a Consumer or non-health professional from UNITED STATES on Aug 18, 2007. Female patient, weighting 20.06 lb, was treated with ADDERALL. After drug was administered, patient experienced the following problems/side effects: abdominal pain, accidental exposure, drooling, heart rate increased, insomnia, lethargy, posture abnormal, stereotypy. ADDERALL dosage: 20 MG, ONE DOSE, ORAL. Patient was hospitalized. Patient recovered.

Physician from UNITED STATES reported ADDERALL problem on Aug 21, 2007. Female patient, 39 years of age, was diagnosed with attention deficit/hyperactivity disorder and was treated with ADDERALL. After drug was administered, patient experienced the following problems/side effects: benign intracranial hypertension, visual disturbance. ADDERALL dosage: 30 MG, 1X/DAY:QD AM, ORAL. During the same period patient was treated with ZOLOFT. Patient recovered.

ADDERALL problem was reported by a Physician from UNITED STATES on Aug 29, 2007. Female patient, 29 years of age, weighting 110.0 lb, was diagnosed with attention deficit/hyperactivity disorder and was treated with ADDERALL. After drug was administered, patient experienced the following problems/side effects: non-cardiac chest pain, syncope. ADDERALL dosage: 20 MG, 1X/DAY; QD; ORAL. During the same period patient was treated with AMBIEN CR, XANAX. Patient recovered.

Consumer or non-health professional from UNITED STATES reported ADDERALL problem on Aug 30, 2007. Male patient, child 8 years of age, was diagnosed with attention deficit/hyperactivity disorder and was treated with ADDERALL. After drug was administered, patient experienced the following problems/side effects: convulsion, electroencephalogram abnormal, hypoaesthesia, irritability, tremor. ADDERALL dosage: 20 MG, 1X/DAY:QD, ORAL; 15 MG, 1X/DAY:QD,ORAL; 25 MG, 1X/DAY:QD, ORAL. During the same period patient was treated with BENADRYL. Patient recovered.

ADDERALL problem was reported by a Physician from UNITED STATES on Sept 20, 2007. Female patient, 56 years of age, weighting 182.0 lb, was diagnosed with attention deficit/hyperactivity disorder and was treated with ADDERALL. After drug was administered, patient experienced the following problems/side effects: blood pressure abnormal, heart rate abnormal. ADDERALL dosage: unknown. Patient recovered.

Health Professional from UNITED STATES reported ADDERALL problem on Sept 21, 2007. Female patient, weighting 110.0 lb, was diagnosed with attention deficit/hyperactivity disorder and was treated with ADDERALL. After drug was administered, patient experienced the following problems/side effects: aggression, suicidal ideation, tremor. ADDERALL dosage: unknown. Patient was hospitalized and became disabled. Patient recovered.

Showing 1-75 of 153 Next >

Ask Our Patient Community about ADDERALL

Select a Medication and Click to Access Reports about Side Effects and Adverse Reactions

A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z
This drug has as active FDA Safety Alert This drug has an active FDA Safety Alert
A
Abacavir sulfate
Abatacept
Abilify
Acamprosate calcium
AccuprilThis drug has as active FDA Safety Alert
AccutaneThis drug has as active FDA Safety Alert
AceonThis drug has as active FDA Safety Alert
Aciphex
Actiq (fentanyl citrate)
ActimmuneThis drug has as active FDA Safety Alert (aripiprazole) (quinapril) (isotretinoin) (perindopril) (rabeprazole) (interferon gamma-1b)
ActonelThis drug has as active FDA Safety Alert (risedronate)
Actoplus MetThis drug has as active FDA Safety Alert (pioglitazone)
ActosThis drug has as active FDA Safety Alert (pioglitazone)
AcuTect (technetium Tc 99m apcitide)
Adefovir dipivoxil
Advair Diskus(Fluticasone propionate; Salmeterol xinafoate)
AdderallThis drug has as active FDA Safety Alert (amphetamine salts)
Agenerase (amprenavir)
Aggrastat (tirofiban)
Alamast (pemirolast)
AlendronateThis drug has as active FDA Safety Alert
AlemtuzumabThis drug has as active FDA Safety Alert
AleveThis drug has as active FDA Safety Alert (naproxen sodium)
Alfuzosin
Alinia (nitazoxanide)
Alimta (pemetrexed)
Alitretinoin
Almotriptan malateThis drug has as active FDA Safety Alert
Alosetron hydrochloride
Aloxi (palonosetron)
Alrex (loteprednol etabonate)
AltaceThis drug has as active FDA Safety Alert (ramipril)
Ambien (zolpidem tartrate)
AmergeThis drug has as active FDA Safety Alert (naratriptan)
Aminolevulinic acid
AmiodaroneThis drug has as active FDA Safety Alert
Amitiza (lubiprostone)
AmnesteemThis drug has as active FDA Safety Alert (isotretinoin)
Amphadase (hyaluronidase)
luronidase)
Amphetamine saltsThis drug has as active FDA Safety Alert
Amprenavir
AnaproxThis drug has as active FDA Safety Alert (naproxen sodium)
Angiomax (bivalirudin)
Anidulafungin
Antagon (ganirelix acetate)
Anthelios SX (avobenzone, ecamsule, octocrylene)
Apidra (insulin glulisine recombinant)
Apokyn (apomorphine)
Aprepitant
Aprotinin
Aptivus (tipranavir)
AranespThis drug has as active FDA Safety Alert (darbepoetin alpha)
Arava (leflunomide)
Arformoterol
Argatroban
ArediaThis drug has as active FDA Safety Alert (pamidronate)
Aripiprazole
Arixtra (fondaparinux)
Aromasin (exemestane)
Arranon (nelarabine)
Arsenic trioxide
Aspirin
Atacand (candesartan cilexetil)
Atazanavir sulfate
AtomoxetineThis drug has as active FDA Safety Alert
Avastin (bevacizumab)
Avelox (moxifloxacin)
Avobenzone, Ecamsule, Octocrylene
Avodart (dutasteride)
Avonex (interferon beta-1a)
AxertThis drug has as active FDA Safety Alert (almotriptan malate)
Azacitidine
Azilect (rasagiline)
Azopt (brinzolamide)

back to top

B
Balsalazide disodium
Baraclude (entecavir)
BenazeprilThis drug has as active FDA Safety Alert
Benicar (olmesartan medoxomil)
Bevacizumab
Bexarotene
BextraThis drug has as active FDA Safety Alert (valdecoxib)
BiaxinThis drug has as active FDA Safety Alert (clarithromycin)
Bimatoprost
Bivalirudin
BonivaThis drug has as active FDA Safety Alert (ibandronate)
Bortezomib
Brinzolamide
Brovana (arformoterol)
BupropionThis drug has as active FDA Safety Alert
Butisol sodium
Byetta (exenatide)


back to top

C
Calfactant
CampathThis drug has as active FDA Safety Alert (alemtuzumab)
Campral (acamprosate calcium)
Cancidas (caspofungin)
Candesartan cilexetil
Capecitabine
CapotenThis drug has as active FDA Safety Alert (captopril)
CaptoprilThis drug has as active FDA Safety Alert
CarbamazepineThis drug has as active FDA Safety Alert
CarbatrolThis drug has as active FDA Safety Alert (carbamazepine)
Carbrital (pentobarbital and carbromal)
Caspofungin
Cefditoren pivoxil
CefepimeThis drug has as active FDA Safety Alert
CeftriaxoneThis drug has as active FDA Safety Alert
CelebrexThis drug has as active FDA Safety Alert (celecoxib)
CelecoxibThis drug has as active FDA Safety Alert
CelexaThis drug has as active FDA Safety Alert (citalopram hydrobromide)
Cetrorelix acetate
Cetrotide (cetrorelix acetate)
Cetuximab
Cevimeline
ChantixThis drug has as active FDA Safety Alert (varenicline)
Cialis (tadalafil)
Cilostazol
Cinacalcet
Cirlesonide
CitalopramThis drug has as active FDA Safety Alert
ClaravisThis drug has as active FDA Safety Alert (isotretinoin)
ClarithromycinThis drug has as active FDA Safety Alert
Clarinex (desloratadine)
Clolar (clofarabine)
Clofarabine
Clozapine
Clozaril (clozapine)
CodeineThis drug has as active FDA Safety Alert
Colazal (balsalazide disodium)
Colesevelam
ColistimethateThis drug has as active FDA Safety Alert
Coly-Mycin M (colistimethate)This drug has as active FDA Safety Alert
Comtan (entacapone)
Concerta (methylphenidate)
Conivaptan
CordaroneThis drug has as active FDA Safety Alert (amiodarone)
CrestorThis drug has as active FDA Safety Alert (rosuvastatin calcium)
Cubicin (daptomycin)
Curosurf (poractant alfa)
CylertThis drug has as active FDA Safety Alert (pemoline)
CymbaltaThis drug has as active FDA Safety Alert (duloxetine)
CytotecThis drug has as active FDA Safety Alert (misoprostol)

back to top

D
Dacogen (decitabine)
Dalfopristin
Dalmane (flurazepam)
Daptomycin
Darbepoetin alphaThis drug has as active FDA Safety Alert
Darifenacin
Darunavir
Dasatinib
Daytrana (methylphenidate transdermal)
DDAVPThis drug has as active FDA Safety Alert (desmopressin)
DDAVP Nasal SprayThis drug has as active FDA Safety Alert (demopressin)
DDAVP Rhinal TubeThis drug has as active FDA Safety Alert (desmopressin)
DDVPThis drug has as active FDA Safety Alert (desmopressin
Decitabine
Deferasirox
Definity (perflutren lipid microspheres)
DepaconThis drug has as active FDA Safety Alert (valproate)
DepakeneThis drug has as active FDA Safety Alert (valproate)
DepakoteThis drug has as active FDA Safety Alert (valproate)
Desloratadine
DesmopressinThis drug has as active FDA Safety Alert
Detrol (tolterodine tartrate)
terodine tartrate)
Dexedrine (dextroamphetamine sulfate)
Dexmedetomidine
Dexmethylphenidate HCl
> Dextroamphetamine sulfate
Diastat AcuDialThis drug has as active FDA Safety Alert
Diazepam rectal gelThis drug has as active FDA Safety Alert
DidronelThis drug has as active FDA Safety Alert (etidronate)
DiprivanThis drug has as active FDA Safety Alert (propofol)
Dofetilide
Doral (quazepam)
Doxercalcif
Drospirenone
DuloxetineThis drug has as active FDA Safety Alert
DuragesicThis drug has as active FDA Safety Alert (fentanyl transdermal system)
Dutasteride

back to top

E

Eculizumab
Edetate disodium
Efalizumab
Efavirenz
EffexorThis drug has as active FDA Safety Alert (venlafaxine)
Elestat (epinastine)
EletriptanThis drug has as active FDA Safety Alert
Elidel (pimecrolimus)
Ellence (epirubicin)
Eloxatin (oxaliplatin)
Emend (aprepitant)
Emtricitabine
Emtriva (emtricitabine)
Enablex (darifenacin)
Enalapril / EnalaprilatThis drug has as active FDA Safety Alert
Endrate (edetate disodium)
Enfuvirtide
Entacapone
Entecavir
Epinastine
Epirubicin
Eplerenone
Epoetin alfaThis drug has as active FDA Safety Alert
EpogenThis drug has as active FDA Safety Alert (epoetin alfa)
Eptifibatide
EquetroThis drug has as active FDA Safety Alert (carbamazepine)
Eraxis (anidulafungin)
Erbitux (cetuximab)
Ertaczo (sertaconazole)
EscitalopramThis drug has as active FDA Safety Alert
Estazolam
Eszopiclone
Ethchlorvynol
Ethinyl estradiol
EtidronateThis drug has as active FDA Safety Alert
Evoxac (cevimeline)
Exelon (rivastigmine tartrate)
Exenatide
Exjade (deferasirox)
Exemestane
Extraneal (icodextrin)
Ezetimibe
Ezetimibe/simvastatin

back to top

 F
Factive (gemifloxacin mesylate)
Faslodex (fulvestrant)
FelbamateThis drug has as active FDA Safety Alert
FelbatolThis drug has as active FDA Safety Alert (felbamate)
Fentanyl buccal tabletsThis drug has as active FDA Safety Alert
Fentanyl citrate
Fentanyl transdermal systemThis drug has as active FDA Safety Alert
FentoraThis drug has as active FDA Safety Alert (fentanyl buccal tablets)
Ferrlecit (sodium ferric gluconate complex)
Fleet Accu-PrepThis drug has as active FDA Safety Alert (sodium phosphate)
Fleet Phospho-SodaThis drug has as active FDA Safety Alert (sodium phosphate)
FluoxetineThis drug has as active FDA Safety Alert
Flurazepam
Fluticasone propionate
FluvoxamineThis drug has as active FDA Safety Alert
Focalin (dexmethylphenidate)
Focalin XR (dexmethylphenidate)
Fomivirsen
Fondaparinux
Foradil (formoterol fumarate)
Formoterol fumarate
FosamaxThis drug has as active FDA Safety Alert (alendronate)
FosinoprilThis drug has as active FDA Safety Alert
FrovaThis drug has as active FDA Safety Alert (frovatriptan succinate)
Frovatriptan succinateThis drug has as active FDA Safety Alert
Fulvestrant
Fuzeon (enfuvirtide)

G
GabapentinThis drug has as active FDA Safety Alert
GabitrilThis drug has as active FDA Safety Alert (tiagabine)
Gadobenate DimeglumineThis drug has as active FDA Safety Alert
GadodiamideThis drug has as active FDA Safety Alert
GadoliniumThis drug has as active FDA Safety Alert
Gadopentetate DimeglumineThis drug has as active FDA Safety Alert
GadoteridolThis drug has as active FDA Safety Alert
GadoversetamideThis drug has as active FDA Safety Alert
GalantamineThis drug has as active FDA Safety Alert
Ganirelix acetate
GatifloxacinThis drug has as active FDA Safety Alert
GefitinibThis drug has as active FDA Safety Alert
Gemifloxacin mesylate
Gemtuzumab ozogamicin
Geodon (ziprasidone)
Gleevec (imatinib mesylate)

back to top

H
Halcion (triazolam)
HaldolThis drug has as active FDA Safety Alert (haloperidol)
HaloperidolThis drug has as active FDA Safety Alert
Hectorol (doxercalcif)
Hepsera (adefovir dipivoxil)
Hyaluronidase
Hydase (hyaluronidase)
Human Secretin

back to top

I
IbandronateThis drug has as active FDA Safety Alert
Ibuprofen
Icodextrin
Iloprost
Imatinib mesylate
Increlex (Mecasermin [rDNA origin]
Infasurf Preservative Free (calfactant)
ImitrexThis drug has as active FDA Safety Alert (sumatriptan)
Innohep (tinzaparin)
Inspra (eplerenone)
Insulin Aspart recombinant
Insulin Detemir recombinant
Insulin Glargine recombinant
Insulin Glulisine recombinant
Intron A (interferon alfa-2b)
Integrilin (eptifibatide)
ifibatide)
Interferon alfa-2b
Interferon beta-1a
Interferon gamma-1bThis drug has as active FDA Safety Alert
Invega (paliperidone)
Iplex  (mecasermin rinfabate)
IressaThis drug has as active FDA Safety Alert (gefitinib)
IsotretinoinThis drug has as active FDA Safety Alert

back to top

J
Januvia (sitagliptin phosphate)

back to top

K
Kaletra (lopinavir; ritonavir)
Kepivance (palifermin)
KeppraThis drug has as active FDA Safety Alert (levetiracetam)
Ketek (telithromycin)
Ketotifen fumarate

back to top

L
LamictalThis drug has as active FDA Safety Alert (lamotrigine)
LamotrigineThis drug has as active FDA Safety Alert
Lantus (insulin glargine recombinant)
Leflunomide
Lenalidomide
Lepirudin recombinant
Levalbuterol
Levemir (insulin detemir recombinant)
LevetiracetamThis drug has as active FDA Safety Alert
Levitra (vardenafil)
Levonorgestrel
Levothyroxine sodium
Levulan Kerastick (aminolevulinic acid)
LexaproThis drug has as active FDA Safety Alert (escitalopram)
Lindane
LinezolidThis drug has as active FDA Safety Alert
LisinoprilThis drug has as active FDA Safety Alert
Lopinavir/ritonavir
Lotemax (loteprednol etabonate)
LotensinThis drug has as active FDA Safety Alert (benazepril)
Loteprednol etabonate
Lotronex (alosetron hydrochloride)
Lubiprostone
Lucentis (ranibizumab)
Lumigan (bimatoprost)
Lunestra (eszopiclone)
LyricaThis drug has as active FDA Safety Alert (pregabalin)

back to top

M
Macugen (pegaptanib)
MagnevistThis drug has as active FDA Safety Alert (gadopentetate dimeglumine)
Maraviroc
MavikThis drug has as active FDA Safety Alert (trandolapril)
MaxaltThis drug has as active FDA Safety Alert (rizatriptan benzoate)
MaxipimeThis drug has as active FDA Safety Alert (cefepime)
Mecasermin [rDNA origin]
Mecasermin-rinfabate
Meloxicam
Memantine
Metadate CD (methylphenidate HCl)
ylphenidate HCl)
Methylphenidate HCl
Methylphenidate transdermal
Mequinol
Micafungin
Micardis (telmisartan)
misartan)
MifeprexThis drug has as active FDA Safety Alert (mifepristone)
MifepristoneThis drug has as active FDA Safety Alert
Miglustat
MinirinThis drug has as active FDA Safety Alert (desmopressin)
MirtazapineThis drug has as active FDA Safety Alert
MisoprostolThis drug has as active FDA Safety Alert
Mobic (meloxicam)
Modafinil
MoexiprilThis drug has as active FDA Safety Alert
MonoprilThis drug has as active FDA Safety Alert (fosinopril)
Moxifloxacin
MultiHanceThis drug has as active FDA Safety Alert (gadobenate dimeglumine)
Mycamine (micafungin)
Mylotarg (gemtuzumab ozogamicin)

back to top

N
Namenda (memantine)
NaprosynThis drug has as active FDA Safety Alert (naproxen)
NaproxenThis drug has as active FDA Safety Alert
Naratriptan
Nesiritide recombinant
Nateglinide
Natrecor (nesiritide recombinant)
NefazodoneThis drug has as active FDA Safety Alert
Nelarabine
NeoTect Kit (technetium Tc 99m depreotide)
Nesiritide recombinant
NeurontinThis drug has as active FDA Safety Alert (gabapentin)
Nexavar (sorafenib)
Nitazoxanide
Nitisinone
Norelgestromin
NovoLog (insulin aspart recombinant)
Noxafil (posaconazole)

back to top

O
Olanzapine
Olanzapine/fluoxetineThis drug has as active FDA Safety Alert
Olmesartan medoxomil
Omacor (omega-3-acid ethyl esters)
OmalizumabThis drug has as active FDA Safety Alert
Omega-3-acid ethyl esters
Omnaris (cirlesonide)
OmniscanThis drug has as active FDA Safety Alert (gadodiamide)
OptiMARK (gadoversetamide)
Optison (perflutren protein-type A microspheres)
Orencia (abatacept)
Orfadin (nitisinone)
Orlistat
Ortho Evra (norelgestromin; ethinyl estradiol)
Oseltamivir phosphate
OsmoprepThis drug has as active FDA Safety Alert (sodium phosphate)
Oxaliplatin
OxcarbazepineThis drug has as active FDA Safety Alert


back to top

P
PaceroneThis drug has as active FDA Safety Alert (amiodarone)
Palifermin
Paliperidone
PamidronateThis drug has as active FDA Safety Alert
Panitumumab
Panretin Gel (alitretinoin)
Pantoprazole
Paricalcitol
ParoxetineThis drug has as active FDA Safety Alert
PaxilThis drug has as active FDA Safety Alert (paroxetine)
Pegaptanib
Pegvisomant
Pemetrexed
PemolineThis drug has as active FDA Safety Alert
Pentobarbital and carbromal
Perflutren lipid microspheres
PerindoprilThis drug has as active FDA Safety Alert
PhenerganThis drug has as active FDA Safety Alert (promethazine)
Pimecrolimus
PioglitazoneThis drug has as active FDA Safety Alert
Placidyl (ethchlorvynol)
Plan B (levonorgestrel)
Pletal (cilostazol)
Poractant alfa
Posaconazole
Pramlintide Acetate
Precedex (dexmedetomidine)
PregabalinThis drug has as active FDA Safety Alert
Prezista (dar